All stories
Jump to date
Friday, June 12 · 3 stories
- Industry
AMA Issues Policy Urging Exemptions in Upcoming Medicaid Work Requirements
The American Medical Association has issued policy guidance calling for exemptions in Medicaid work requirements expected to be implemented in multiple states. The AMA's position addresses work requirement policies that states may pursue following federal regulatory changes. The timing aligns with several states preparing to implement or expand work requirement programs. This matters for Medicaid managed care organizations because MCOs are typically responsible for verifying member compliance with work requirements and managing eligibility transitions, which adds administrative burden and affects member retention.
- Industry
Digital Behavioral Health Providers Shift AI Strategy from Copilots to Clinical Decision Support
Digital behavioral health companies are moving beyond AI copilot tools toward integrated clinical decision-making systems where AI, clinicians, and supervisors collaborate. This represents a strategic shift in how AI is deployed in behavioral health care delivery, moving from administrative assistance to clinical judgment support. The change reflects growing confidence in AI capabilities and evolving regulatory frameworks around AI in healthcare. For Medicaid managed care organizations contracting with digital behavioral health vendors, this transition will affect care quality metrics, clinical oversight requirements, and potentially liability and compliance frameworks.
- Industry
Health Plans Report AI Documentation Tools Driving Commercial Cost Increases
Nearly 70% of health plans surveyed by PwC identified providers' use of AI documentation and coding tools as a top three trend inflating commercial healthcare costs in the coming year. The report highlights concerns that AI-enabled coding may generate more comprehensive documentation and higher-acuity billing, potentially increasing claim volumes and costs. The findings reflect commercial market trends, as these AI tools are increasingly adopted across healthcare settings. Health plans are responding by evaluating claims review processes and utilization management protocols.
Wednesday, June 10 · 3 stories
- Industry
Average Drug Shortage Duration Reaches 5.3 Years in 2025
A new analysis shows the average drug shortage in 2025 has lasted 5.3 years, up from 4.3 years in 2024. The extended duration reflects chronic supply chain instability affecting generic medications, many of which are used extensively in Medicaid populations. The analysis highlights growing challenges in maintaining formulary stability and managing therapeutic alternatives. For Medicaid managed care plans, prolonged shortages complicate prior authorization processes, increase member access issues, and drive utilization of more expensive therapeutic substitutes.
- Industry
Health Systems Expand In-House Specialty Pharmacy Operations Amid 340B Restrictions
Health systems are increasingly establishing their own specialty pharmacy operations in response to tightening reimbursement and manufacturer restrictions on 340B contract pharmacy arrangements. Hospitals and health systems now represent the fastest-growing segment of direct participants in the specialty pharmacy market. The shift is driven by both revenue generation goals and manufacturers' evolving 340B policies that limit contract pharmacy access. This infrastructure buildout allows health systems to capture specialty drug dispensing margins and maintain access to 340B savings despite manufacturer restrictions.
- Industry
U.S. Drug Shortages Fell 23% in 2024 Despite Ongoing Systemic Supply Issues
Prescription drug shortages in the United States decreased by 23% in 2024 according to a new analysis, but systemic supply chain problems persist. The analysis identified ongoing structural vulnerabilities in pharmaceutical manufacturing and distribution that continue to affect medication availability. While the overall number of shortages declined, the duration and severity of certain shortages worsened. For Medicaid managed care organizations, drug shortages create formulary management challenges, increase member access barriers, and complicate pharmacy benefit administration when preferred products become unavailable.
Monday, June 8 · 7 stories
- Industry
Eli Lilly 340B Deadline Passes, Noncompliant Hospitals Lose Discounts
Eli Lilly's June 1 deadline for hospitals to submit claims data to maintain 340B drug discounts has passed without HRSA intervention. Hospitals that failed to comply with Lilly's data submission requirements will lose access to discounted pricing on covered drugs. HRSA has not responded to requests from hospital and pharmacy groups to intervene in the dispute. The action affects hospitals participating in the 340B program that purchase Lilly medications.
- Industry
Three Hospital Closures Reported in Early 2026, Down from 13 Year Prior
Three U.S. hospitals and emergency departments closed in early 2026, compared to 13 at the same point in 2025. Total closures in 2025 reached 23, nearly matching the 25 reported in 2024. The article suggests the early 2026 slowdown may not indicate structural improvement in hospital financial stability. The trend continues a multi-year pattern of hospital closures driven by financial pressures.
- Industry
NASHP Hosts Webinar on Rural Health Payment Reform Models
The National Academy for State Health Policy (NASHP) will hold a webinar on June 16, 2026, from 3–4 p.m. ET focusing on payment reform strategies for rural health settings. The session will explore collaborative learning opportunities around alternative payment models designed for rural providers. Rural health care delivery intersects with Medicaid managed care in states where MCOs serve rural populations or where rural providers participate in value-based payment arrangements.
- Industry
Health Economist Calls for New Payment Infrastructure for Gene Therapies
Health economist William Padula argues that high-cost gene therapies, including treatments costing $2 million or more, require new financing models to enable patient access. The commentary asserts that the barrier to deploying curative therapies is not scientific but financial and infrastructural. Padula contends that existing payment systems are ill-equipped to handle the upfront costs of one-time curative treatments. The piece calls for innovative financing mechanisms to bridge the gap between therapeutic breakthroughs and patient access.
- Industry
ADA Conference Highlights Obesity Drug Competition and Clinical Practice Gaps
The American Diabetes Association's annual conference featured industry discussions on the competitive landscape for GLP-1 obesity medications and identified clinical blind spots in diabetes care delivery. The conference addressed how pharmaceutical competition is shaping market access and pricing dynamics for widely-used medications including semaglutide and tirzepatide. For Medicaid managed care organizations, these developments directly affect formulary strategy, prior authorization protocols, and budget forecasting for one of the fastest-growing drug spending categories.
- Industry
Trump Administration Adds 160 Drugs to TrumpRx Direct-to-Consumer Platform
President Trump announced Friday that TrumpRx.gov will add 160 prescription medications to its direct-to-consumer platform, bringing the total to over 800 drugs available at discounted prices. This marks the second expansion of the initiative in two months. The platform sells drugs directly to consumers, bypassing traditional pharmacy channels. The announcement did not specify which drugs were added or provide details about pricing structures or manufacturer participation.

- Industry
20% of U.S. Adults Report Denial of Doctor-Recommended Care
A new Commonwealth Fund study found that one in five U.S. adults were denied doctor-recommended care, leading to deteriorating health outcomes and financial strain. The research highlights increasing patient frustration with claims review processes and prior authorization barriers. Insurers maintain their utilization management protocols are medically appropriate. The findings come as regulatory scrutiny of managed care denial practices intensifies at both federal and state levels.
Friday, June 5 · 1 story
- Industry · NC
Novant Health Reports 1,595 Bed Days Saved Through Hospital-at-Home Program
Novant Health's 19-hospital system launched a hospital-at-home program at Hanover Regional Medical Center in Wilmington, North Carolina, saving 1,595 inpatient bed days. The health system is advocating for expanded private payer coverage of the care model and seeking federal legislation to make hospital-at-home a permanent option beyond current emergency waivers. The program allows acute-care patients to receive hospital-level services in their homes, reducing facility capacity strain while maintaining care quality.
Thursday, June 4 · 1 story
- Industry · NY
Westchester Medical Center Partners with MVP Health Care on Care Coordination
Westchester Medical Center Health Network in New York has launched a partnership with MVP Health Care to improve care coordination for hospitalized patients and during discharge transitions. MVP clinical care managers will be embedded in hospital care teams and will continue supporting members after they return home. The partnership aims to reduce readmissions and improve care continuity. The arrangement reflects growing collaboration between health systems and payers on care transition programs.
Wednesday, June 3 · 1 story
- Industry
Providers and Insurers Deploy AI Tools for Prior Authorization and Claims Battles
Healthcare providers and insurers are increasingly using artificial intelligence to automate prior authorization requests and claims denials, creating an escalating technological arms race in medical billing. Providers use AI to generate documentation and appeals, while payers deploy AI to review and deny claims at scale. The automation may reduce administrative burden but also risks accelerating denials without human clinical judgment. This trend affects Medicaid managed care organizations that already face scrutiny over prior authorization delays and denial rates.
Tuesday, June 2 · 2 stories
- Industry
Eli Lilly Threatens to Cut 340B Discounts for Hospitals Refusing Data Sharing
Eli Lilly has issued an ultimatum to certain 340B hospitals requiring them to share data proving they are not duplicating drug discounts by Monday or face loss of 340B pricing. The pharmaceutical company claims some hospitals refuse to provide documentation showing compliance with program requirements prohibiting duplicate Medicaid and 340B discounts on the same claim. Hospitals are pushing back and requesting federal government intervention. The dispute centers on manufacturer attempts to limit 340B discounts amid concerns about program integrity and duplicate discounting.
- Industry · NC
Trump Rural Health Fund Excludes Closed Hospital Reopening Efforts
A proposed $50 billion rural health funding package championed by Congressional Republicans is not expected to support efforts to reopen closed rural hospitals, including Martin County, North Carolina's shuttered facility. The funding structure appears focused on operational support for existing facilities rather than capital investment for reopening closed hospitals. Rural hospital closures have accelerated over the past decade, leaving gaps in access to emergency and inpatient services. The exclusion raises questions about how federal rural health investment will address communities that have already lost their hospitals.
Monday, June 1 · 4 stories
- Industry
Telehealth Companies Expand GLP-1 Access Amid Safety and Screening Concerns
Telehealth platforms have rapidly scaled access to GLP-1 weight loss medications in response to surging patient demand. Researchers and physicians have raised concerns that some online providers may not adequately screen patients for contraindications or provide appropriate clinical monitoring during treatment. The safety questions emerge as telehealth prescribing of these high-cost medications expands outside traditional clinical settings. The controversy affects how managed care organizations evaluate telehealth vendor networks and pharmacy benefit management for GLP-1 drugs.
- Industry · MN
Minnesota Hospitals Provide Limited Charity Care Despite Growing Uninsured Population
An investigation of Minnesota hospital data reveals most facilities provide minimal financial assistance to uninsured patients and create barriers to accessing charity care programs. The analysis examined hospital charity care spending and program accessibility as the state's uninsured population grows. The findings highlight systemic gaps in the healthcare safety net that affect uninsured individuals who may be eligible for Medicaid but face enrollment barriers or fall into coverage gaps. These charity care shortfalls increase the likelihood that uninsured patients delay care or accumulate medical debt, potentially affecting downstream Medicaid enrollment and emergency department utilization patterns.